998 related articles for article (PubMed ID: 17381663)
1. Management of drug-interaction alerts in community pharmacies.
Indermitte J; Beutler M; Bruppacher R; Meier CR; Hersberger KE
J Clin Pharm Ther; 2007 Apr; 32(2):133-42. PubMed ID: 17381663
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and patient awareness of selected potential drug interactions with self-medication.
Indermitte J; Reber D; Beutler M; Bruppacher R; Hersberger KE
J Clin Pharm Ther; 2007 Apr; 32(2):149-59. PubMed ID: 17381665
[TBL] [Abstract][Full Text] [Related]
3. Preventing drug interactions by online prescription screening in community pharmacies and medical practices.
Halkin H; Katzir I; Kurman I; Jan J; Malkin BB
Clin Pharmacol Ther; 2001 Apr; 69(4):260-5. PubMed ID: 11309555
[TBL] [Abstract][Full Text] [Related]
4. Compliance with national guidelines for the management of drug-drug interactions in Dutch community pharmacies.
Buurma H; Schalekamp T; Egberts AC; De Smet PA
Ann Pharmacother; 2007 Dec; 41(12):2024-31. PubMed ID: 17971404
[TBL] [Abstract][Full Text] [Related]
5. Pharmacist workload and pharmacy characteristics associated with the dispensing of potentially clinically important drug-drug interactions.
Malone DC; Abarca J; Skrepnek GH; Murphy JE; Armstrong EP; Grizzle AJ; Rehfeld RA; Woosley RL
Med Care; 2007 May; 45(5):456-62. PubMed ID: 17446832
[TBL] [Abstract][Full Text] [Related]
6. Physicians' decisions to override computerized drug alerts in primary care.
Weingart SN; Toth M; Sands DZ; Aronson MD; Davis RB; Phillips RS
Arch Intern Med; 2003 Nov; 163(21):2625-31. PubMed ID: 14638563
[TBL] [Abstract][Full Text] [Related]
7. Survey of drug-related problems identified by community pharmacies.
Hämmerlein A; Griese N; Schulz M
Ann Pharmacother; 2007 Nov; 41(11):1825-32. PubMed ID: 17925500
[TBL] [Abstract][Full Text] [Related]
8. Overrides of medication alerts in ambulatory care.
Isaac T; Weissman JS; Davis RB; Massagli M; Cyrulik A; Sands DZ; Weingart SN
Arch Intern Med; 2009 Feb; 169(3):305-11. PubMed ID: 19204222
[TBL] [Abstract][Full Text] [Related]
9. Assessing the value of electronic prescribing in ambulatory care: a focus group study.
Weingart SN; Massagli M; Cyrulik A; Isaac T; Morway L; Sands DZ; Weissman JS
Int J Med Inform; 2009 Sep; 78(9):571-8. PubMed ID: 19395307
[TBL] [Abstract][Full Text] [Related]
10. Drug safety alert generation and overriding in a large Dutch university medical centre.
van der Sijs H; Mulder A; van Gelder T; Aarts J; Berg M; Vulto A
Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):941-7. PubMed ID: 19579216
[TBL] [Abstract][Full Text] [Related]
11. Determinants of potential drug-drug interaction associated dispensing in community pharmacies in the Netherlands.
Becker ML; Caspers PW; Kallewaard M; Bruinink RJ; Kylstra NB; Heisterkamp S; de Valk V; van der Veen AA; Stricker BH
Pharm World Sci; 2007 Apr; 29(2):51-7. PubMed ID: 17187223
[TBL] [Abstract][Full Text] [Related]
12. Pharmacists' awareness of clinical decision support in pharmacy information systems: an exploratory evaluation.
Hines LE; Saverno KR; Warholak TL; Taylor A; Grizzle AJ; Murphy JE; Malone DC
Res Social Adm Pharm; 2011 Dec; 7(4):359-68. PubMed ID: 21530417
[TBL] [Abstract][Full Text] [Related]
13. Potential drug interactions and duplicate prescriptions among cancer patients.
Riechelmann RP; Tannock IF; Wang L; Saad ED; Taback NA; Krzyzanowska MK
J Natl Cancer Inst; 2007 Apr; 99(8):592-600. PubMed ID: 17440160
[TBL] [Abstract][Full Text] [Related]
14. Drug related problems identified by European community pharmacists in patients discharged from hospital.
Paulino EI; Bouvy ML; Gastelurrutia MA; Guerreiro M; Buurma H;
Pharm World Sci; 2004 Dec; 26(6):353-60. PubMed ID: 15683106
[TBL] [Abstract][Full Text] [Related]
15. Community pharmacists' prescription intervention practices--exploring variations in practice in Norwegian pharmacies.
Mandt I; Horn AM; Ekedahl A; Granas AG
Res Social Adm Pharm; 2010 Mar; 6(1):6-17. PubMed ID: 20188324
[TBL] [Abstract][Full Text] [Related]
16. Clinical risk management in Dutch community pharmacies: the case of drug-drug interactions.
Buurma H; De Smet PA; Egberts AC
Drug Saf; 2006; 29(8):723-32. PubMed ID: 16872246
[TBL] [Abstract][Full Text] [Related]
17. Pharmacists' views on Indigenous health: is there more that can be done?
Stoneman J; Taylor SJ
Rural Remote Health; 2007; 7(3):743. PubMed ID: 17688377
[TBL] [Abstract][Full Text] [Related]
18. Reasons provided by prescribers when overriding drug-drug interaction alerts.
Grizzle AJ; Mahmood MH; Ko Y; Murphy JE; Armstrong EP; Skrepnek GH; Jones WN; Schepers GP; Nichol WP; Houranieh A; Dare DC; Hoey CT; Malone DC
Am J Manag Care; 2007 Oct; 13(10):573-8. PubMed ID: 17927462
[TBL] [Abstract][Full Text] [Related]
19. An empirical model to estimate the potential impact of medication safety alerts on patient safety, health care utilization, and cost in ambulatory care.
Weingart SN; Simchowitz B; Padolsky H; Isaac T; Seger AC; Massagli M; Davis RB; Weissman JS
Arch Intern Med; 2009 Sep; 169(16):1465-73. PubMed ID: 19752403
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the clinical value of pharmacists' modifications of prescription errors.
Buurma H; De Smet PA; Leufkens HG; Egberts AC
Br J Clin Pharmacol; 2004 Nov; 58(5):503-11. PubMed ID: 15521898
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
